Exploring the Molecular Basis for Binding of Inhibitors by Threonyl-tRNA Synthetase from Brucella Abortus: A Virtual Screening Study
Overview
Chemistry
Molecular Biology
Affiliations
Targeting threonyl-tRNA synthetase (ThrRS) of Brucella abortus is a promising approach to developing small-molecule drugs against bovine brucellosis. Using the BLASTp algorithm, we identified ThrRS from Escherichia coli (EThrRS, PDB ID 1QF6), which is 51% identical to ThrRS from Brucella abortus (BaThrRS) at the amino acid sequence level. EThrRS was used as the template to construct a BaThrRS homology model which was optimized using molecular dynamics simulations. To determine the residues important for substrate ATP binding, we identified the ATP-binding regions of BaThrRS, docked ATP to the protein, and identified the residues whose side chains surrounded bound ATP. We then used the binding site of ATP to virtually screen for BaThrRS inhibitors and got seven leads. We further characterized the BaThrRS-binding site of the compound with the highest predicted inhibitory activity. Our results should facilitate future experimental effects to find novel drugs for use against bovine brucellosis.
Latipudin D, Tumilaar S, Ramdani Y, Dudi D, Kurnia D Vet Med Sci. 2024; 10(6):e70042.
PMID: 39315732 PMC: 11420939. DOI: 10.1002/vms3.70042.
Small Molecule Inhibitors against the Bacterial Pathogen .
Wu Y, Guo Y, Ma Y, Yu H, Wang Z Curr Med Chem. 2023; 31(27):4267-4285.
PMID: 37718522 DOI: 10.2174/0929867331666230915153910.